Independent of ErbB1 gene copy number, EGF stimulates migration but is not associated with cell proliferation in non-small cell lung cancer

• Processo: 13/09125-0
• Modalidade de apoio: Auxílio à Pesquisa - Publicações científicas - Artigo
• Data de Início da vigência: 01 de junho de 2013
• Data de Término da vigência: 30 de novembro de 2013
• Área do conhecimento: Ciências Biológicas - Morfologia - Citologia e Biologia Celular
• Pesquisador responsável: Glaucia Maria Machado Santelli
• Beneficiário: Glaucia Maria Machado Santelli
• Instituição Sede: Instituto de Ciências Biomédicas (ICB). Universidade de São Paulo (USP). São Paulo , SP, Brasil
• Assunto(s): Biologia tumoral Neoplasias pulmonares Movimento celular Fator de crescimento epidérmico Proteínas tirosina quinases Publicações de divulgação científica Artigo científico
• Palavra(s)-Chave do Pesquisador: cell migration | epidermal growth factor | epidermal growth factor receptor | lung cancer | proliferation | tyrosine kinase inhibitor | biologia tumoral

Resumo

Lung cancer often exhibits molecular changes, such as the overexpression of the ErbB1 gene. ErbB1 encodes epidermal growth factorreceptor (EGFR), a tyrosine kinase receptor, involved mainly in cell proliferation and survival. EGFR overexpression has been associated with more aggressive disease, poor prognosis, low survival rate and low response to therapy. ErbB1amplification and mutation are associated with tumor development and are implicated in ineffective treatment. The aim of the present study was toinvestigate whether the ErbB1 copy number affects EGFR expression, cell proliferation or cell migration by comparing two different cell lines. Methods:The copies of ErbB1 gene was evaluated by FISH. Immunofluorescence and Western blotting were performed to determine location and expression of proteins mentioned in the present study. Proliferation was studied by flowcytometry and cell migration by wound healing assay and time lapse. Results: We investigated the activation and function of EGFR in the A549 and HK2 lung cancer cell lines, which contain 3 and 6 copies of ErbB1, respectively. Theexpression of EGFR was lower in the HK2 cell line. EGFR was activated after stimulation with EGF in both cell lines, but this activation did not promote differences in cellular proliferation when compared to control cells. InhibitingEGFR with AG1478 did not modify cellular proliferation, confirming previousdata. However, we observed morphological alterations, changes in microfilament organization and increased cell migration upon EGF stimulation. However, these effects did not seem to be consequence of an epithelialmesenchymaltransition. Conclusion: EGFR expression did not appear to be associated to the ErbB1 gene copy number, and neither of these aspects appeared to affect cell proliferation. However, EGFR activation by EGF resulted in cell migration stimulation in both cell lines. (AU)